ArticleJournal of gastrointestinal oncology2023

Efficacy and safety of toripalimab with fruquintinib in the third-line treatment of refractory advanced metastatic colorectal cancer: results of a single-arm, single-center, prospective, phase II clinical study.

Shoucheng Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.